Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 893 results for "for merck"

Merck Completes Tender Offer To Acquire Cubist

European Ad Comm gives thumbs up to Merck investigational anti...

News Editor The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts a positive opinion recommending approval for Merck's (MRK +0.2%) Sivextro (tedizolid phosphate) for the treatment of acute bacterial skin and ... Seeking Alpha, 19 hours ago

83 images for for merck, 4 hours ago
Njbiz, 4 days ago
Natural News, 1 day ago, 5 days ago
Labmate Online, 9 hours ago
Labmate Online, 9 hours ago, 2 hours ago
Pharma Letter, 1 week ago
Cleanroom Technology, 2 days ago
Citybizlist, 5 days ago
Labmate Online

Merck & Co. Inc. (MRK) Closes 0.53% Up on the Day for January 26

Dow Jones component Merck & Co. Inc. ($MRK) saw its stock move 0.53% to $62.82, representing a per-share move of $0.33, on volume of 6.71 million shares for Monday. Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves ...
 Equities.com7 hours ago New System for Immunohistochemistry Minimises S...  Labmate Online10 hours ago Merck & Co. (MRK) to Stop Selling Once-Hot Hep C Drug Victrelis 1/23/2015  ClinicSpace13 hours ago Merck & Co. Receives $63.67 Consensus Target Price from Analysts (NYSE:MRK)  Ticker Report1 day ago

Merck (MRK) Showing Resistance Near $63.22

Merck & Co Inc. ("MRK) is a good candidate for a covered call at the $60.00 level. The Jun. '15 call at that price should fetch a credit of about $4.10, which means the entire position has a net ...
 Individual.com21 hours ago Trade of the Day: Merck (MRK)  InvestorPlace.com3 days ago Merck (MRK) Showing Bullish Technicals With Resistance At $63.46  Individual.com3 days ago Potential Merck (MRK) Trade Has 3.19% Downside Protection  Individual.com1 week ago

Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health

Asia's biggest vaccine maker is working on a string of new low-priced offerings that threaten to undercut brands from the world's biggest pharmaceutical companies. Serum Institute of India Ltd., which makes vaccines injected in 65 percent of the ...
 BusinessWeek18 hours ago

SITC : Merck to Support Innovative Cancer Immunotherapy Research

The Society for Immunotherapy of Cancer (SITC) is cultivating the next generation of cancer immunotherapy researchers by providing dedicated funding for the development of innovative treatment strategies, aiming to make the word "cure" a reality for ...
 4 Traders15 hours ago SITC, Merck to Support Innovative Cancer Immunotherapy Research  MySanAntonio6 hours ago Immunotherapy trials shift breast cancer research closer to Holy Grail  Orthopedics Today19 hours ago

Merck (MRK) Approaches New Downside Target of $61.64

Merck (NYSE:MRK) has opened bearishly below the pivot of $62.34 today and has reached the first level of support at $61.90. Should the shares continue to fall, the support pivots of $61.64 and $60.94 will be
 Individual.com4 days ago Watch for Shares of Merck (MRK) to Approach Support at $61.64  Individual.com4 days ago

Johnson and Johnson And Merck and Co Ebola Vaccine Trials Face Shortage Of Volunteers

Some major pharmaceutical firms, which are currently developing Ebola vaccines, are facing difficulties due to the decreasing number of reported cases of Ebola virus in West Africa. The experimental vaccines are under consideration for being ...
 Bidness Etc3 days ago Johnson & Johnson And Merck & Co Ebola Vaccine Trials Face Shortage Of Volunteers  FirstWord Pharma3 days ago

Hanwha Chemical to export biosimilar technology to Germany's Merck

South Korea-based drugmaker Hanwha Chemical will license out its biosimilar of an arthritis drug Enbrel to a German multinational pharmaceutical firm, Merck KGaA. This is the first time that the domestic drugmaker will export a biosimilar, developed ...
 Maekyung4 days ago

ELI LILLY : Lilly, Merck Sign Collaboration Deal

Merck and Eli Lilly and Company reported an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical ...
 4 Traders6 days ago Merck enters into clinical trial collaboration with Eli Lilly  Individual.com1 week ago Eli Lilly and Company, Merck enter collaboration agreement  Financial Express1 week ago
Manitoba Cooperator

Report: Merck said to be testing lower dosage Zilmax to revive sales

Fieldwork at Texas Tech began more than a year after the cattle growth drug was pulled Share Tools Merck ($MRK) is financing a $1.85 million study being conducted at Texas Tech University to see if lower dosages of its lucrative but ...
 Fierce Biotech Research2 days ago Merck and Co. Provides Funds To Test Cattle Growth Drug Zilmax At Lower Doses  Bidness Etc5 days ago Merck funds tests of lower Zilmax doses as seen seeking way to resume sales  Sharenet1 week ago Exclusive: Merck funds tests of lower Zilmax doses as seen seeking way to resume sales  Reuters UK1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less